Literature DB >> 19243257

Quantitative analysis of 90Y Bremsstrahlung SPECT-CT images for application to 3D patient-specific dosimetry.

Cinzia Fabbri1, Graziella Sarti, Marta Cremonesi, Mahila Ferrari, Amalia Di Dia, Monica Agostini, Francesca Botta, Giovanni Paganelli.   

Abstract

AIM: The aim of this study was to evaluate the accuracy of the activity quantification of single-photon emission computed tomography/computed tomography (SPECT-CT) (90)Y-Bremsstrahlung images and to validate the S-voxel method.
METHODS: An anthropomorphic torso phantom with radioactive inserts ((90)Y) was acquired by SPECT-CT. Constant calibration factors (cps/MBq) for the quantification were evaluated, considering different volume, shape, position inside the phantom, activity concentration and background, and distance from detectors. S-voxel values (EGSnrc) were implemented in MATLAB R0086 USA software. Dose comparisons between S-voxel and the conventional Medical Internal Radiation Dose method were repeated in a group of 11 patients administered with (90)Y-DOTATATE.
RESULTS: Using the appropriate calibration factors to recover the volume variability, the error about the measurement repeatability and the activity variation was within 4%. The variability of activity quantification, depending on the position in the phantom, detector distance, and background, was <10%, <5%, and <10%, respectively. The absorbed-dose values calculated by OLINDA were in agreement with the mean dose values obtained by the S-voxel method (difference, <10%).
CONCLUSIONS: The results confirm that, with the hybrid SPECT-CT system, quantitative analysis of SPECT (90)Y-Bremsstrahlung images and the generation of three-dimensional dose distributions are feasible. The improved analysis of Bremsstrahlung images could have a notable clinical impact, allowing to address the dosimetric verification to patients during the course of therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19243257     DOI: 10.1089/cbr.2008.0543

Source DB:  PubMed          Journal:  Cancer Biother Radiopharm        ISSN: 1084-9785            Impact factor:   3.099


  20 in total

Review 1.  Dosimetry of yttrium-labelled radiopharmaceuticals for internal therapy: 86Y or 90Y imaging?

Authors:  Stephan Walrand; Glenn D Flux; Mark W Konijnenberg; Roelf Valkema; Eric P Krenning; Renaud Lhommel; Stanislas Pauwels; Francois Jamar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-03-11       Impact factor: 9.236

2.  ⁹⁰Y-based PET and SPECT/CT imaging in locoregional brain treatment for high-grade gliomas: retrospective fusion with MRI.

Authors:  Cinzia Fabbri; Vincenzo Mattone; Graziella Sarti; Michela Casi; Francesco De Lauro; Monica Agostini; Nerio Bartolini; Mirco Bartolomei
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-08-08       Impact factor: 9.236

Review 3.  The role of SPECT/CT in radioembolization of liver tumours.

Authors:  Hojjat Ahmadzadehfar; Heying Duan; Alexander R Haug; Stephan Walrand; Martha Hoffmann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-01-18       Impact factor: 9.236

4.  99mTc-MAA/ 90Y-Bremsstrahlung SPECT/CT after simultaneous Tc-MAA/90Y-microsphere injection for immediate treatment monitoring and further therapy planning for radioembolization.

Authors:  Hojjat Ahmadzadehfar; Amir Sabet; Marianne Muckle; Kai Wilhelm; Karl Reichmann; Hans-Jürgen Biersack; Samer Ezziddin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-02-26       Impact factor: 9.236

5.  The significance of bremsstrahlung SPECT/CT after yttrium-90 radioembolization treatment in the prediction of extrahepatic side effects.

Authors:  Hojjat Ahmadzadehfar; Marianne Muckle; Amir Sabet; Kai Wilhelm; Christiane Kuhl; Kim Biermann; Torjan Haslerud; Hans-Jürgen Biersack; Samer Ezziddin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-02       Impact factor: 9.236

6.  Semi-Quantitative Analysis of Post-Transarterial Radioembolization (90)Y Microsphere Positron Emission Tomography Combined with Computed Tomography (PET/CT) Images in Advanced Liver Malignancy: Comparison With (99m)Tc Macroaggregated Albumin (MAA) Single Photon Emission Computed Tomography (SPECT).

Authors:  Seunghong Rhee; Sungeun Kim; Jaehyuk Cho; Jukyung Park; Jae Seon Eo; Soyeon Park; Eunsub Lee; Yun Hwan Kim; Jae-Gol Choe
Journal:  Nucl Med Mol Imaging       Date:  2015-09-14

7.  Individualized dosimetry-based activity reduction of ⁹⁰Y-DOTATOC prevents severe and rapid kidney function deterioration from peptide receptor radionuclide therapy.

Authors:  Sofie Van Binnebeek; Kristof Baete; Bert Vanbilloen; Christelle Terwinghe; Michel Koole; Felix M Mottaghy; Paul M Clement; Luc Mortelmans; Karin Haustermans; Eric Van Cutsem; Alfons Verbruggen; Kris Bogaerts; Chris Verslype; Christophe M Deroose
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-03-26       Impact factor: 9.236

8.  High quality imaging and dosimetry for yttrium-90 (90Y) liver radioembolization using a SiPM-based PET/CT scanner.

Authors:  Heying Duan; Mohamed H Khalaf; Valentina Ferri; Lucia Baratto; Shyam M Srinivas; Daniel Y Sze; Andrei Iagaru
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-01-14       Impact factor: 9.236

9.  MRI-based biodistribution assessment of holmium-166 poly(L-lactic acid) microspheres after radioembolisation.

Authors:  Gerrit H van de Maat; Peter R Seevinck; Mattijs Elschot; Maarten L J Smits; Hendrik de Leeuw; Alfred D van Het Schip; Maarten A D Vente; Bernard A Zonnenberg; Hugo W A M de Jong; Marnix G E H Lam; Max A Viergever; Maurice A A J van den Bosch; Johannes F W Nijsen; Chris J G Bakker
Journal:  Eur Radiol       Date:  2012-09-27       Impact factor: 5.315

Review 10.  Current Status of Radiopharmaceutical Therapy.

Authors:  Sara St James; Bryan Bednarz; Stanley Benedict; Jeffrey C Buchsbaum; Yuni Dewaraja; Eric Frey; Robert Hobbs; Joseph Grudzinski; Emilie Roncali; George Sgouros; Jacek Capala; Ying Xiao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-08-14       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.